ANDA 85517, held by Abbott. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 85517 (A-Poxide), held by Abbott, was first approved by FDA on Jul 1, 1977, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 1, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| A-Poxide5MG ยท capsule;oral | Chlordiazepoxide Hydrochloride | Discontinued |
| Jan 25, 1984 | Supplement 9Manufacturing | Approved | None posted |
| Mar 31, 1982 | Supplement 6Manufacturing | Approved | None posted |
| Mar 31, 1982 | Supplement 7Manufacturing | Approved | None posted |
| Jul 1, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters